There's been a lot of speculation about this being bad for other health related startups, etc. But I don't think so. To be a valid comparison, your startup would have to be perceived to have a confluence of factors shielding it from accountability: A combination of long tenure (Theranos is 13 years old) + huge amount of funding (this co. has $750M+) + a very politically influential board appear to be shielding Theranos from typical consequences of non-verified innovation (contrary to standard scientific process) and resistance to directly address specific allegations of misconduct (in tech process, company operations, among personnel etc).